New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation.
Tripodi, A
New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation. [electronic resource] - Journal of internal medicine Jun 2012 - 554-65 p. digital
Publication Type: Journal Article; Review
1365-2796
10.1111/j.1365-2796.2012.02541.x doi
Anticoagulants--therapeutic use
Atrial Fibrillation--complications
Benzimidazoles--pharmacology
Clinical Trials as Topic
Clinical Trials, Phase III as Topic
Dabigatran
Drugs, Investigational
Heparin--therapeutic use
Humans
International Normalized Ratio
Morpholines--pharmacology
Pyrazoles--pharmacology
Pyridones--pharmacology
Rivaroxaban
Stroke--etiology
Thiophenes--pharmacology
Treatment Outcome
Venous Thromboembolism--etiology
Vitamin K--antagonists & inhibitors
beta-Alanine--analogs & derivatives
New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation. [electronic resource] - Journal of internal medicine Jun 2012 - 554-65 p. digital
Publication Type: Journal Article; Review
1365-2796
10.1111/j.1365-2796.2012.02541.x doi
Anticoagulants--therapeutic use
Atrial Fibrillation--complications
Benzimidazoles--pharmacology
Clinical Trials as Topic
Clinical Trials, Phase III as Topic
Dabigatran
Drugs, Investigational
Heparin--therapeutic use
Humans
International Normalized Ratio
Morpholines--pharmacology
Pyrazoles--pharmacology
Pyridones--pharmacology
Rivaroxaban
Stroke--etiology
Thiophenes--pharmacology
Treatment Outcome
Venous Thromboembolism--etiology
Vitamin K--antagonists & inhibitors
beta-Alanine--analogs & derivatives